<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04021251</url>
  </required_header>
  <id_info>
    <org_study_id>RSP-16</org_study_id>
    <nct_id>NCT04021251</nct_id>
  </id_info>
  <brief_title>Performance Characteristics of Non-invasive Glucose Monitoring Device Prototypes</brief_title>
  <official_title>Performance Characteristics of Non-invasive Glucose Monitoring Device Prototypes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RSP Systems A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RSP Systems A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study has been launched to collect spectral raman data paired with validated&#xD;
      glucose reference values in private homes of subjects&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will collect either 8 or 44 daily optical raman readings paired with either 8&#xD;
      capillary Blood Glucose comparator or 8 capillary Blood Glucose comparator plus 44 readings&#xD;
      using a flash glucose monitoring system in own home with maintaining usual routines. Subjects&#xD;
      will either collect data for 5 days during a 10 days period or collect data for 90 days&#xD;
      during a 40 days period or collect data for 90 days during 6 months period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Generation of predictive algorithms for determining blood glucose levels</measure>
    <time_frame>3 years</time_frame>
    <description>Collected spectral raman data will found the development of predictive algorithms for glucose determination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Validation of predictive algorithms for determining blood glucose levels</measure>
    <time_frame>3 years</time_frame>
    <description>Performance of predictive models will be evaluated using the consensus error grid.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Short term collection of IMD data</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will collect spectral raman data on P0.2 for minimum 10 hours per day with a maximum of 15 minutes between each measurement for 5 days distributed over a time period of 10 days. Spectral data will be compared to standard BG and/or FGM measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium term collection of IMD data</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will collect spectral raman data on P0.2 for four times a day for 30 days distributed over a time period of 40 days. Spectral data will be compared to standard BG measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long term collection of IMD data</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will collect spectral raman data on P0.2 for four times a day for 90 days distributed over a time period of 6 months. Spectral data will be compared to standard BG measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium term collection of IMD data, increased # of sessions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will collect spectral raman data on P0.2 four times a day for 30 days distributed over a time period of 40 days. Spectral data will be compared to standard BG measurements. The number of optical sessions performed each time measurements are done are increased compared to the investigation's second arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>P0.2</intervention_name>
    <description>Investigational Medical Device collecting spectral raman data from tissue.</description>
    <arm_group_label>Long term collection of IMD data</arm_group_label>
    <arm_group_label>Medium term collection of IMD data</arm_group_label>
    <arm_group_label>Medium term collection of IMD data, increased # of sessions</arm_group_label>
    <arm_group_label>Short term collection of IMD data</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female subjects 18 years of age or older&#xD;
&#xD;
          -  Diabetic patients (all types)&#xD;
&#xD;
          -  Skin phototype 1-4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  For female participants: Pregnancy or subject is attempting to conceive or not willing&#xD;
             and able to practice birth control during the study duration&#xD;
&#xD;
          -  For female participants: Breastfeeding&#xD;
&#xD;
          -  Subjects not able to understand and read Danish&#xD;
&#xD;
          -  In Investigator's opinion, subject is not able to follow instructions as specified in&#xD;
             the protocol&#xD;
&#xD;
          -  Participants not able to hold hand/arm steadily (including tremors and Parkinson's&#xD;
             Disease)&#xD;
&#xD;
          -  Diagnosed with reduced circulation&#xD;
&#xD;
          -  Extensive skin changes, tattoos or diseases on probe application site&#xD;
&#xD;
          -  Known allergy to medical grade alcohol&#xD;
&#xD;
          -  Known allergy to adhesives, applicable to subjects in RSP-16-01&#xD;
&#xD;
          -  Systemic or topical administration of glucocorticoids for the past 7 days and under&#xD;
             investigation&#xD;
&#xD;
          -  Participants undergoing dialysis treatment&#xD;
&#xD;
          -  Medical history or any condition that may, in the opinion of the Investigator,&#xD;
             compromise the subject's ability to participate&#xD;
&#xD;
          -  Concomitant medical condition which could present a risk to the safety or welfare of&#xD;
             the subject or study staff.&#xD;
&#xD;
          -  Participants currently enrolled in another study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Erik Henriksen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital, Dpt. of Endocrinology M</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Ovesen Banke, MSc</last_name>
    <phone>+45 71 99 79 77</phone>
    <email>stefan@rspsystems.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Endocrinology M</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Erik Henriksen, MD</last_name>
      <phone>+45 65411811</phone>
      <email>Jan.Erik.Henriksen@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2019</study_first_posted>
  <last_update_submitted>August 13, 2020</last_update_submitted>
  <last_update_submitted_qc>August 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

